Pau Gorostiza Archives - Institute for Bioengineering of Catalonia

November 21, 2023

Luminescent Nanoparticle-based Implants for Pain and Epilepsy Treatment

The IBEC is set to lead the coordination of the PHOTOTHERAPORT project, which will be developed with funding from the European Innovation Council’s Pathfinder Open programme. The project focuses on the development of luminescent implants and light-activated drugs for innovative neuromodulation therapies. PHOTOTHERAPORT will comprise an international consortium of 8 institutions and will receive €3 million over 3 years for the preclinical study of these implants.

October 25, 2023

Researchers induce brain activation using infrared light-controlled drugs

A pioneering study led by IBEC in collaboration with ICFO has unveiled a method to control brain activity in living organisms using drugs activated by infrared light. This cutting-edge technique activates a specific neurotransmitter receptor using light that can penetrate deep into tissue and offers unparalleled pharmacological and spatiotemporal precision in three dimensions. The findings open new frontiers for neurobiology research and the development of light-based noninvasive neuromodulation therapies.

March 27, 2023

First clinical mentoring for IBEC doctoral students in Barcelona hospitals

close up. pharmacists discussing a new drug in the laboratory .

The Clinical Immersion Program for PhD students is an initiative Entrepreneurship Program of the IBEC and the College of Physicians of Barcelona (CoMB). Its objective is to connect IBEC doctoral … Read more

October 28, 2022September 13, 2022

Postdoc2/ at the nanoprobes and nanoswitches Research Group

<img width="800" height="418" src="https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card.jpg" class="attachment-full size-full wp-post-image" alt="" itemprop="image" decoding="async" loading="lazy" srcset="https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card.jpg 800w, https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card-300x157.jpg 300w, https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card-768x401.jpg 768w, https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card-150x78.jpg 150w" sizes="(max-width: 800px) 100vw, 800px" />

Postdoctoral / Deadline September 23th

October 28, 2022September 13, 2022

Postdoc/ at the nanoprobes and nanoswitches Research Group

<img width="800" height="418" src="https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card.jpg" class="attachment-full size-full wp-post-image" alt="" itemprop="image" decoding="async" loading="lazy" srcset="https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card.jpg 800w, https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card-300x157.jpg 300w, https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card-768x401.jpg 768w, https://ibecbarcelona.eu/wp-content/uploads/2021/07/wearehiring_tw-card-150x78.jpg 150w" sizes="(max-width: 800px) 100vw, 800px" />

Postdoctoral / Deadline 23th September 2022

September 15, 2022May 20, 2022

The first light-controlled drug that could improve the hearing of people with cochlear implants

Researchers at the Institute for Bioengineering of Catalonia (IBEC) in Spain and the University Medical Center Göttingen in Germany achieve, for the first time, in vivo light-activated auditory stimulation without the need for genetic manipulation. This new light-controlled drug, capable of triggering the neural pathways involved in hearing, can contribute to improving the spectral resolution of cochlear implants used by people with profound hearing loss or deafness.

April 1, 2022March 25, 2022

ONCE visits IBEC to learn about the research in bioengineering for health

On February 15th, representatives of the National Organization of the Spanish Blind (ONCE) visited the Institute for Bioengineering of Catalonia (IBEC) to learn, first-hand and among others, about the innovative research work of Professor Pau Gorostiza’s Group in regenerative therapies of vision.

June 23, 2021June 18, 2021

Controlling brain states with light

A study led by researchers from IBEC and IDIBAPS achieves, for the first time, the control of brain state transitions using a molecule responsive to light.

June 21, 2021June 17, 2021

Controlling brain states with a ray of light

A study led by researchers from IBEC and IDIBAPS achieves, for the first time, the control of brain state transitions using a molecule responsive to light, named PAI. The results not only pave the way to act on the brain patterns activity, but they also could lead to the development of photomodulated drugs for the treatment of brain lesions or diseases such as depression, bipolar disorders or Parkinson’s or Alzheimer’s diseases.

May 7, 2021

New molecules allow to switch on and off neuronal circuits using light

Researchers from IBEC, in collaboration with an international team, describe the first molecules capable of regulate glycine receptors with light: Glyght and Azo-NZ1. The new molecules are a promising way to study neuronal circuits, to develop drug-based phototherapies non-invasively, and to understand neurological disorders related with the incorrect functioning of glycine receptors, as hyperekplexia, epilepsy and autism.